Literature DB >> 17375091

Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?

Sarah L Rowland-Jones1, Hilton C Whittle.   

Abstract

Most people infected with human immunodeficiency virus 2 (HIV-2) do not progress to disease, even though the minority who do cannot be distinguished clinically from HIV-1-infected patients. Here we review what is known about the basis of viral control in HIV-2 infection.

Entities:  

Mesh：

Year:  2007        PMID： 17375091     DOI： 10.1038/ni0407-329

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  32 in total

1.  Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.

Authors:  Rui Kong; Hui Li; Frederic Bibollet-Ruche; Julie M Decker; Natalie N Zheng; Geoffrey S Gottlieb; Nancy B Kiviat; Papa Salif Sow; Ivelin Georgiev; Beatrice H Hahn; Peter D Kwong; James E Robinson; George M Shaw
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

2.  Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection.

Authors:  Mohammad Khalid; Hangxing Yu; Daniel Sauter; Shariq M Usmani; Jan Schmokel; Jerome Feldman; Rob A Gruters; Marchina E van der Ende; Matthias Geyer; Sarah Rowland-Jones; Albert D Osterhaus; Frank Kirchhoff
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  Constitutive resistance to viral infection in human CD141+ dendritic cells.

Authors:  Aymeric Silvin; Chun I Yu; Xavier Lahaye; Francesco Imperatore; Jean-Baptiste Brault; Sylvain Cardinaud; Christian Becker; Wing-Hong Kwan; Cécile Conrad; Mathieu Maurin; Christel Goudot; Santy Marques-Ladeira; Yuanyuan Wang; Virginia Pascual; Esperanza Anguiano; Randy A Albrecht; Matteo Iannacone; Adolfo García-Sastre; Bruno Goud; Marc Dalod; Arnaud Moris; Miriam Merad; A Karolina Palucka; Nicolas Manel
Journal:  Sci Immunol       Date:  2017-07-07

4.  Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.

Authors:  Maarten F Schim van der Loeff; Natasha Larke; Steve Kaye; Neil Berry; Koya Ariyoshi; Abraham Alabi; Carla van Tienen; Aleksandra Leligdowicz; Ramu Sarge-Njie; Zacharias da Silva; Assan Jaye; Dominique Ricard; Tim Vincent; Sarah Rowland Jones; Peter Aaby; Shabbar Jaffar; Hilton Whittle
Journal:  Retrovirology       Date:  2010-05-19       Impact factor: 4.602

Review 5.  Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?

Authors:  A Boasso; G M Shearer; C Chougnet
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

6.  Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection.

Authors:  David Gautier; Stéphanie Beq; Catarina S Cortesão; Ana E Sousa; Rémi Cheynier
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection.

Authors:  Anna Bergamaschi; Diana Ayinde; Annie David; Erwann Le Rouzic; Marina Morel; Gilles Collin; Diane Descamps; Florence Damond; Françoise Brun-Vezinet; Sebastien Nisole; Florence Margottin-Goguet; Gianfranco Pancino; Catherine Transy
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

8.  Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression.

Authors:  Jérôme Feldmann; Aleksandra Leligdowicz; Assan Jaye; Tao Dong; Hilton Whittle; Sarah L Rowland-Jones
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

Review 9.  Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection.

Authors:  Samuele E Burastero; Mariangela Figini; Barbara Frigerio; Paolo Lusso; Luca Mollica; Lucia Lopalco
Journal:  J Transl Med       Date:  2009-11-28       Impact factor: 5.531

10.  Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.

Authors:  Rita Cavaleiro; António P Baptista; Rui S Soares; Rita Tendeiro; Russell B Foxall; Perpétua Gomes; Rui M M Victorino; Ana E Sousa
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.